Zymeworks Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ZYME Nasdaq 2834 www.zymeworks.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Zymeworks Inc.

Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth - Apr 9th, 2026 4:00 am
Exchange-Traded Funds, Equity Futures Gain Pre-Bell Wednesday as Iran War De-Escalation Hopes Drive Sentiment - Apr 1st, 2026 7:06 am
Zymeworks Appoints Kristin Stafford as Chief Financial Officer - Apr 1st, 2026 4:00 am
How Investors May Respond To Zymeworks (ZYME) Fast Track Nod For Ovarian Cancer ADC ZW191 - Mar 31st, 2026 2:16 am
Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate - Mar 30th, 2026 4:00 am
Zymeworks Announces Participation in Upcoming Investor Conferences - Mar 24th, 2026 4:00 am
Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting - Mar 18th, 2026 5:46 am
Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting - Mar 17th, 2026 3:02 pm
Zymeworks Leans On Zanidatamab Results To Build Royalty Focused Model - Mar 3rd, 2026 3:07 am
Zymeworks Inc (ZYME) Q4 2025 Earnings Call Highlights: Strategic Milestones and Financial Resilience - Mar 2nd, 2026 2:01 pm
Zymeworks Q4 Earnings Call Highlights - Mar 2nd, 2026 8:37 am
Zymeworks Inc. Q4 2025 Earnings Call Summary - Mar 2nd, 2026 6:30 am
Zymeworks Inc. (ZYME) Reports Q4 Loss, Lags Revenue Estimates - Mar 2nd, 2026 5:15 am
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing - Mar 2nd, 2026 4:10 am
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing - Mar 2nd, 2026 4:01 am
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results - Mar 2nd, 2026 4:00 am
Alkermes (ALKS) Q4 Earnings and Revenues Top Estimates - Feb 25th, 2026 10:15 am
Investor Slashes $70 Million From Zymeworks as Stock Jumps 60% in a Year - Feb 22nd, 2026 11:13 am
Zymeworks To Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 2, 2026 - Feb 12th, 2026 4:00 am
A Look At Zymeworks (ZYME) Valuation After Recent Share Price Pullback - Jan 28th, 2026 7:18 pm